POSTERIOR · WIRE
InjuryBOSSep 20, 2026, 8:36 PM EDTSignal confidence 85%

Alex Bregman exits game after foul ball strikes him in the face in on-deck circle

Alex Bregman left a Red Sox game after being hit in the face by a foul ball in the on-deck circle, per MLB.com's Bill Ladson; test results are pending.

Posterior generated visual for Boston Red Sox: Alex Bregman exits game after foul ball strikes him in the face in on...

Alex Bregman was struck in the face by a foul ball while waiting in the on-deck circle and did not return to the game, MLB.com's Bill Ladson reported. Test results were still pending at the time of the report.

What happened

Per Bill Ladson's report for MLB.com, Bregman was in the on-deck circle — not at the plate, not in the field, but in that particular patch of real estate that players have occupied under the working assumption that it is the safe part of the batter's box experience — when a foul ball found him. He exited the game. The club was awaiting test results.

No diagnosis has been reported. No timetable has been offered. The report does not describe the specific nature of the injury beyond the location of impact.

Why it matters

Bregman is a cornerstone of a Boston lineup navigating a genuinely consequential stretch of the schedule. The Red Sox, at 84-72, are eliminated from the AL East division race but sit second in the Wild Card standings, +4.0 relative to the cut line. That margin is meaningful but not comfortable, and every lineup card matters when the calendar reads late September.

The timing also lands against a backdrop of accumulating health questions in the Boston clubhouse. A week removed from Willson Contreras being hit by a pitch on the hand, the Red Sox are still managing Contreras's availability — he believes he avoided a fracture, per earlier reporting, but his hand remained very sore and his status uncertain as of the most recent updates. Aroldis Chapman has been dealing with shoulder soreness, raising questions about the postseason bullpen picture. Garrett Crochet and Tanner Houck have been making progress in rehab and moving toward returns, per reporting from earlier this week, but neither is back yet.

Into that context, a Bregman face injury — with test results still outstanding — is not a footnote. It is another variable in a roster equation that already has several unknowns.

Where the club stands

Boston's record stands at 84-72 (.538), good for third place in the AL East, 11.5 games back in the division. The Wild Card picture is the operative one: the Red Sox rank second in the Wild Card standings, sitting +4.0 above the cut line. They have dropped their last two games, entering this moment on an L2 streak.

The Red Sox are eliminated from the division race and playing for Wild Card position. At +4.0 relative to the cut line, there is cushion — but the final weeks of a pennant race have a way of making cushion feel thinner than arithmetic suggests.

Boston's upcoming schedule features three home games against the Cleveland Guardians at Fenway Park. Tuesday, September 22 is set to feature Payton Tolle against Parker Messick. Wednesday, September 23 has Sonny Gray lined up opposite Foster Griffin. Thursday, September 24 has Ranger Suarez scheduled, with Cleveland's starter listed as TBD.

That is a three-game series against a club that will have its own October ambitions, and the Red Sox will be working through it with at least some uncertainty about who is available and in what capacity.

Is Bregman available going forward?

That is precisely what the test results are meant to answer, and those results had not been reported at the time of Bill Ladson's MLB.com piece. No timetable has been offered, no diagnosis has been made public, and no roster move has been reported in connection with the injury.

Under general league rules, a player who sustains a head or facial injury may be placed on the 7-day concussion injured list if a concussion is involved — but no such determination has been reported here, and attaching any specific mechanism to this situation would go beyond what the material supports. What is known is that Bregman left the game and the club was waiting on information.

What we don't know yet

The test results themselves are the central unknown. Until those come back and the club addresses them, the scope of the injury — and what it means for Bregman's availability against Cleveland and beyond — remains open.

It is also worth noting that the report does not specify which game this occurred in, the inning, or the score at the time of Bregman's exit. The operational question of how the Red Sox managed the remainder of that game without him is not addressed in the available material.

The broader postseason health picture for Boston remains unsettled independent of this development. Chapman's shoulder soreness, Contreras's hand, and the ongoing rehab timelines for Crochet and Houck all represent threads that the club is managing simultaneously. Tyron Guerrero was activated from the injured list earlier this week, returning a bullpen arm as that picture takes shape — but the rotation and lineup depth questions are still being answered in real time.

What to watch

The most immediate thing to monitor is whatever the Red Sox report regarding Bregman's test results. A clean bill of health would be significant news for a lineup that cannot easily absorb an extended absence from one of its primary contributors at this point in the season.

Beyond Bregman specifically, the Cleveland series beginning Tuesday represents a meaningful block of games for Boston's Wild Card positioning. The +4.0 margin above the cut line is the number to keep in mind — it is a lead, but it is a lead that requires tending. How the Red Sox construct their lineup and bullpen over the next several days, given everything currently in motion on the health front, will be worth watching closely.

Bill Ladson's report for MLB.com noted that test results were pending. When those results are reported, the picture will sharpen considerably.

02 / Posterior Lens
03 / Adjacent

More on the Red Sox wire.